IL1B and Parkinson disease: Since neuroinflammation is a hallmark of PD, we assessed if treatment with MPTP for 6 h also induced the pro-inflammatory marker cytokine interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α).